Clinical Trial Results: Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety, PK/PD, and dose escalation/expansion of PXS-5505 in patients with myelofibrosis (including PMF and post-PV/post-ET MF); trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• PXS-5505 (PXS-5505)

Snippet

Sponsor: Syntara | Conditions: Myelofibrosis, Primary Myelofibrosis (PMF) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-08-04